for protein-protein complexes, which is remarkable given the small size of the 34-residue pro-segment. The pro-segment and catalytic domain interact through a balance of favorable hydrophobic interactions complemented by an array of hydrogen bonds and salt bridges, the same forces that shape affinity and selectivity of intermolecular protein-protein interactions (Xu et al., 1997) . The extensive nature of the broad interface between pro-segment and catalytic domain suggests the possibility that the pro-segment may be capable of inhibiting the enzyme in trans, and serving as a template for engineering protein-based mirolysin inhibitors of therapeutic utility. Similar approaches have shown promise for engineering therapeutic inhibitors of ADAM family metallopeptidases, based upon their much larger pro-domains (Moss et al., 2007; Wong et al., 2016) .
Guevara, Rodriguez-Banqueri et al. further report a highresolution structure of active mirolysin bound to a peptide product, providing insight into determinants of substrate specificity of the protease (Guevara et al., 2020) . A preference of mirolysin for cleavage on the N-terminal side of basic residues (Koneru et al., 2017) is explained by the presence of an aspartate residue positioned to form a salt bridge with the substrate. This aspartate residue is conserved among the pappalysin family of metalloproteases to which mirolysin belongs, suggesting that similar specificity may be typical of the entire family, and that the mirolysin structure can offer a model to understand substrate recognition for the larger family. Additionally, this serendipitously trapped product complex may provide yet another starting point from which active site-targeted mirolysin inhibitors might be developed. A similar serendipitous discovery of a product fragment captured in a crystal structure of MMP-13 recently led to the design of a potent peptidomimetic inhibitor of this metalloprotease (Gall et al., 2019) . Together the new structures of mirolysin reported here offer a window from which to understand the function of this protease in gum disease, with a glimpse of how one might inhibit this intriguing target.
Figure 1
Structure of promirolysin reveals how the pro-segment inhibits enzyme activity prior to proteolytic activation. The N-terminal residues of the pro-segment (salmon) occupy the active site cleft of the catalytic domain (gray), with a key cysteine residue coordinating the catalytic zinc ion (purple). This figure was generated using Pymol from the coordinates of PDB structure 6r7v, reported in this issue by Guevara, Rodriguez-Banqueri et al.
